2."From ""Human Nature"" to ""Medicine Nature""- Analysis of Moral Emotion Education of Medical Students"
Chinese Medical Ethics 2016;29(5):792-794
Moral emotion education of medical students should begin with arousing human nature of students and making them to have the sense of consciousness to patients, which takes sympathy as the core. However, when faced with the increase of doctor-patient contradiction, students are easy to suspect the general sense. So students should be guided to understand the necessity of moral emotion in professional activity of doctors, and thus to adhere to treat patients with emotion due to responsibility. On this basis, through combining the education of having emo-tion to patient with working reasonably, medical students will gradually take treating patients with emotion as their own compulsory emotion, and to realize the transformation from human nature to medicine nature.
3.Tumor-associated miRNA and apoptosis
Journal of International Oncology 2009;36(11):803-806
MicroRNA,known as micro-RNA or miRNA,is a class of small non-coding RNA whose ma-ture products is ~22 nucleotides long.It negatively regulates gene expression at the post-transcriptional lev-el.More and more studies confirm the important role of miRNA in carcinogenesis and tumor development by reg-ulating cell apoptosis,and the research focuses on tumor-associated miRNA in tumor cell apoptosis may bring widest perspective on treatment and diagnosis of tumor in the future.
4.Update in the management of asthma during pregnancy.
Chinese Journal of Practical Internal Medicine 2001;0(04):-
The prevalence of asthma in pregnant women appears to be increasing.Pregnant women with uncontrolled asthma may have an increased risk of adverse perinatal outcomes.Optimal management of asthma during pregnancy includes avoiding or controlling asthma triggers,individualized pharmacologic therapy,objective monitoring of lung function,and patient education.Inhaled corticosteroids are the preferred treatment for the management of all levels of persistent asthma during pregnancy.It is safer for pregnant women with asthma to be treated with asthma medications than to have asthma symptoms and exacerbations.The goal of asthma management during pregnancy is to optimize maternal and fetal health.
5.Preparation and characterization of amphotericin B-polybutylcyanoacrylate nanoparticles
Academic Journal of Second Military Medical University 2000;0(10):-
Objective:To prepare amphotericin B(AmB)-polybutylcyanoacrylate(PBCA) nanoparticle and evaluate its characteristics,so as to screen for the optimal preparation technique.Methods: AmB was loaded to blank PBCA nanoparticles by incubation to prepare AmB-PBCA nanoparticles.The surface of the nanoparticles was modified with polysorbate 80.The AmB concentration of AmB-PBCA-NP solution was calculated with the standard curve of AmB at D_(405),and the stability of solution was assessed.The diameter distribution of the particles was determined with Coulter Laser granulometer.The colloid solution of AmB-PBCA-NP was centrifuged and the supernatant was harvested to determine the concentration of AmB.The encapsulation rate,drug loading rate,and in vitro drug release were measured.The optimized preparation recipe was screened using diameter,drug loading rate,and encapsulation rate of the particles as indices.Results: The prepared AmB-PBCA nanoparticle had a regular spherical or elliptic surface,with a mean diameter of(69.01?28.56) nm.The curve of standard AmB was linear within the range of 1.12-5.60 ?g/ml: D_(405)=0.163 4c+0.006 6(r=0.999 3).The average recovery of AmB-PBCA-NP was(99.93%,) showing the solution of AmB-PBCA-NP was stable within 12 h.The nanoparticles showed a sustained drug release in vitro within 24 h.The optimized recipe was: DextranT-70 stabilizer without sodium deoxycholate,with a mean encapsulation rate of 56.10% and a drug loading rate of 82%.Conclusion: The current method for preparing AmB-PBCA nanoparticles is simple and can meet the requirements of pharmaceutics.
6.Alternations of Some Enzymological Characterizations of Site-mutagenized DNA Polymerase ?
Academic Journal of Second Military Medical University 1985;0(05):-
The enzymological characterizations of site-mutagenized rat recombinant DNA polymerase?, RQ182 and RQ183 were studied The phosphocellulose column chromatographies showed that the mutant and the wild DNA polymerases were all eluted by about 0.5 mol/ L KCI, but the denatured DNA-cellulose chromatographies showed that although the wild enzyme was eluted by 0.35 mol/L KCI, RQ182 and RQ183 were eluted by 0.55 and 0.45 mol/L KCI, respectively, indicating that the binding abilities to DNA of the mutant enzymes were increased. Km values for the substrate (dTTP)of the wild enzyme, RQ182 and RQ183 were determined as 38.5, 34.5 and 111.1 ?mol/L, respectively,and the Km values for the primer (oligo(dT)) were 1.28, 1.96 and 6.58 ?g/ml, respectively. The results showed that the affinities of RQ183 to the substrate and the primer were decreased dramatically. It is suggested that Arg182 and Arg183 were involved in the active site function of DNA polymerase ?, in binding to DNA template, in recognizing of primer, and in binding to and catalyzing of substrates of the enzyme.
7.Study on the associations between HLA antigens and Mixed Connective Tissue Disease(MCTD)
Chinese Journal of Immunology 1985;0(01):-
In this report,We performed HLA-A、—B and DR antigens typing and detected antibodies to U_1RNP ploypeptide antigen by Immunblotting in 37 patients with MCTD.The results showed that (1)there were no significant differences between the MCTD patients and normal controls in the frequencies of HLA—A,—B antigens.(2)there were significant differences between patients fulfilling sharp's criteria and normal controls in the frequencies of DR4 and R5 (60.9%,RR=4.7,Pc0.05).(3)the frequencies of DR4 and R5 in MCTD patients with myositis were increasedcompared with these without myositis(P0.05).
8.The treatment effect observation of patients with type 2 diabetes mellitus (T2DM) using avandia combined with insulin
Journal of Chongqing Medical University 2007;0(10):-
Objective:In order to observe the effect of avandia combined with insulin to treat patients with type 2 diabetes mellitus(T2DM). Methods:Seventy two patients whose blood sugar was not controlled well by hypodermic were randomized devided into two groups. Group A was administered insulin alone,Group B was administered insulin and avandia. Fast plasma glucose(FPG),blood sugar 2 hours following meals,HbA1c,plasm insulin and exogenetic insulin doses,etc. Results:FPG,blood sugar 2 hours following meals,HbA1c,plasm insulin level and exogenetic insulin dose were all decreased. Conclusion:Using avandia combined with insulin to treat patients with T2DM can lower blood sugar level of patients and improve insulin resistance. [
9.Study of efficacy on lipo PGE1 in treatment of diabetic nephropathy
Journal of Chongqing Medical University 1987;0(01):-
Objective:To observe the effects of Lipo PGE1 in Treatment of Diabetic nephropathy(DN).Methods:60 patients with clinical albuminuria were divided randomly into the treatment group and control group,receiving regular treatment.In addition,the cases of treatment group received treatment of PGE1 10?g daily for two weeks.The index of Scr and UAER were observed before and after treatment.Results:The Scr and UAER in treatment group were more decreased than those in control group.Conclusion:Lipo PGE1 is effective in treating Diabetic nephropathy.
10.A comparison of premixed insulin aspart 30 and premixed human insulin 30R in treatment of type 2 diabetes
Journal of Chongqing Medical University 1986;0(03):-
Objective:To compare the safety and efficacy of premixed insulin aspart 30 (BIAsp30) with premixed human insulin 30R (BHI30)used in twice-daily injection regimen in patients with type 2 diabetes. Methods:Sixty-eight patients with inadequate glycemia control by oral drug were randomly divided into two groups using twice-daily insulin for 12 weeks comparison of BIAsp30 and BHI30. We compared HbA1c,seven-point blood glucose and frequency of hypoglycemia in two groups. Results:Blood glucose after breakfast and after dinner were significantly lower in BIAsp30 group than in BHI30 group(P0.05),meanwhile no serious hypoglycemia happened in BIAsp30 group. Conclusion:Post-prandial glycemia control was significantly improved,without increasing the risk of hypoglycemia,when people with type 2 diabetes were treated in twice-daily injection regimen with BIAsp30,as compared with BHI30.